JS207 Combination Therapy in Triple-negative Breast Cancer

Clinical trial NCT07045311 · RECRUITING

Trial details

NCT number: NCT07045311
Sponsor: Shanghai Junshi Bioscience Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Triple-negative Breast Cancer

Start date: 2025-09-17
Primary completion: 2028-03-22
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.